Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections

Clinical Microbiology and Infection

Volumn 16, Issue 2, 2010, Pages 147-151

  Azap, O K ^a   Arslan, H ^a   Serefhanoglu K ^a   Colakoglu S ^a   Erdogan H ^a   Timurkaynak, F ^a   Senger, S S ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Community acquired urinary tract infection; E. coli; ESBL enzyme types; ESBL positivity; Risk factors

Indexed keywords

BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; COTRIFAMOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COHORT ANALYSIS; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LOCALIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ESCHERICHIA COLI; NEGIBACTERIA;

EID: 74549120901     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02941.x     Document Type: Article

References (19)

1. Rodriguez-Bano J, Alcala JC, Cisneros JM. Community infections caused by extended spectrum beta lactamase producing Escherichia coli. Arch Intern Med 2008, 168:1897-1902.
2. Apisarnthanarak A, Kiratisin P, Mundy LM. Predictors of mortality from community-onset bloodstream infections due to extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2008, 29:671-674.
3. Coque TM, Novais A, Carattoli A. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 2008, 14:195-200.
4. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008, 61:273-281.
5. Yumuk Z, Afacan G, Nicolas-Chanoine MH. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J Antimicrob Chemother 2008, 62:284-288.
6. Rodriguez-Bano J, Navarro MD, Romero L. Epidemiology and clinical features of infections caused by extended-spectrum beta lactamase producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004, 42:1089-1094.
7. Sobel JD, Kaye D, Mandell GL, Bennett JE, Dolin R. Urinary tract infections. Principles and practice of infectious diseases 2005, 875-905. In, eds, Philadelphia, PA, Churchill Livingstone
8. 2008, Performance standards for antimicrobial susceptibility testing; Eeighteenth informational supplement. CLSI Document M100-S18, Wayne, PA, CLSI
9. Saladin M, Cao V, Lambert T. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 2002, 209:161-168.
10. Arslan H, Azap ÖK, Ergönül Ö, Timurkaynak F. Risk factors for ciprofloxacin resistance among E. coli strains isolated from community acquired urinary tract infections in Turkey. J Antimicrob Chemother 2005, 56:914-918.
11. Calbo E, Romani V, Xercavins M. Risk factors for community onset urinary tract infections due to Escherichia coli harbouring extended spectrum beta lactamases. J Antimicrob Chemother 2006, 57:780-783.
12. Colodner R, Rock W, Chazan B. Risk factors for the development of extended-spectrum beta-lactamase producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 2004, 23:163-167.
13. Yi{dotless}lmaz E, Akali{dotless}n H, Özbey S. Risk factors in community acquired/onset urinary tract infections due to extended-spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae. J Chemother 2008, 20:581-585.
14. Canbaz S, Peksen Y, Sunter AT. Antibiotic prescribing and urinary tract infection. Int J Antimicrob Agents 2002, 20:407-411.
15. Knottnerus BJ, Nys S, ter Riet G. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in the Netherlands? J Antimicrob Chemother 2008, 62:356-359.
16. Ena J, Francisco A, Martinez-Peinado C. Epidemiology of urinary tract infections caused by extended spectrum beta lactamase producing Escherichia coli. Urology 2006, 68:1169-1174.
17. Lagace-Wiens PRS, Nichol KA, Nicolle LE. Treatment of lower urinary tract infection caused by multi-drug resistant extended-spectrum beta lactamase producing E. coli with amoxicillin/clavulonate: case report and characterization of the isolate. J Antimicrob Chemother 2006, 57:1262-1263.
18. Aktaş Z, Gönüllü N, Schneider I. Detection of CTX-M-15 type extended spectrum beta-lactamase in an Escherichia coli strain isolated from the urine sample of a hospitalized patient. Mikrobiyol Bul 2005, 39:421-429.
19. Friedman ND, Kaye KS, Stout JE. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community acquired infections. Ann Intern Med 2002, 137:791-797.